Current Report Filing (8-k)
June 30 2021 - 7:57AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) June 24, 2021
Daxor
Corporation
(Exact
name of registrant as specified in its charter)
New
York
|
|
811-22684
|
|
13-2682108
|
(State
or other jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
109
Meco Lane, Oak Ridge, TN
|
|
37830
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
212-330-8500
Registrant’s
telephone number, including area code
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions ( see General Instruction A.2. below):
[ ]
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered
pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock $0.01 par value
|
|
DXR
|
|
NYSE
AMERICAN
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Potential
persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays
a currently valid OMB control number.
Item
5.07 Submission of Matters to a Vote of Security Holders
The
Company’s Annual Meeting was held June 24, 2021. At the Annual Meeting, the following directors were elected for terms expiring
at the annual meeting of shareholders to be held in 2022 by the votes indicated:
|
|
For
|
|
|
Withheld
|
|
|
Broker
Non-votes
|
|
James Lombard
|
|
|
2,964,273
|
|
|
|
12,584
|
|
|
|
387,427
|
|
Henry D. Cremisi, MD
|
|
|
2,966,805
|
|
|
|
10,052
|
|
|
|
387,427
|
|
Edward Feuer
|
|
|
2,967,285
|
|
|
|
9,572
|
|
|
|
387,427
|
|
Joy Goudie, Esq.
|
|
|
2,966,805
|
|
|
|
10,052
|
|
|
|
387,427
|
|
Michael Feldschuh
|
|
|
2,898,106
|
|
|
|
78,751
|
|
|
|
387,427
|
|
Jonathan Feldschuh
|
|
|
2,898,106
|
|
|
|
78,751
|
|
|
|
387,427
|
|
The
following reflects the voting results for matters other than the election of directors brought for vote at the Annual Meeting:
|
|
For
|
|
|
Against
|
|
|
Abstain
|
|
|
Broker
Non-votes
|
|
Ratification of WithumSmith+Brown, PC as Daxor Corporation’s independent registered public accounting firm
|
|
|
3,354,996
|
|
|
|
6,033
|
|
|
|
3,255
|
|
|
|
0
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized.
|
DAXOR
CORPORATION
|
|
(Registrant)
|
|
|
Date:
June 30, 2021
|
By:
|
/s/
Robert J. Michel
|
|
Name:
|
Robert
J. Michel
|
|
Title:
|
Chief
Financial Officer
|
Daxor (AMEX:DXR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Daxor (AMEX:DXR)
Historical Stock Chart
From Jul 2023 to Jul 2024